Observational Study Describing the Immune Profile Induced By Pertussis Vaccines

A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation With Bordetella Pertussis Using Controlled Human Infection

NCT06903221 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age

NCT00467519 ·Status: COMPLETED ·Phase: PHASE3

Pertussis Maternal Immunization Study

NCT00553228 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis

NCT06827470 ·Status: RECRUITING ·Phase: PHASE1

Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age

NCT01346293 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness of Adacel Vaccination in Pregnancy at Preventing Pertussis in Infants < 2 Months of Age in the United States

NCT05040802 ·Status: COMPLETED

Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years

NCT01529645 ·Status: COMPLETED ·Phase: PHASE1

Pertussis Vaccine in Healthy Pregnant Women

NCT00707148 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary Vaccine Regimens in Republic of South Africa

NCT04300192 ·Status: COMPLETED ·Phase: PHASE4

Influence of BCG on TDaP-IPV Vaccination

NCT02771782 ·Status: UNKNOWN ·Phase: PHASE4

Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

NCT00802867 ·Status: COMPLETED ·Phase: PHASE4

Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia

NCT03188458 ·Status: TERMINATED ·Phase: PHASE4

Immunogenicity of a Combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) Vaccine in Healthy Toddlers

NCT07213089 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Duration of Protection: GSK DTaP Vaccines

NCT02447978 ·Status: COMPLETED

Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy Adults

NCT03541499 ·Status: COMPLETED ·Phase: PHASE2

Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children

NCT05116241 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine

NCT07203755 ·Status: RECRUITING ·Phase: PHASE1

10-year Follow-up After a Single Dose Acellular Pertussis Vaccination

NCT06803524 ·Status: RECRUITING ·Phase: PHASE4

3-year Follow-up After a Single Dose Acellular Pertussis Vaccination

NCT04102137 ·Status: COMPLETED

Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine

NCT00662870 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Adults

NCT06798831 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

5-year Follow-up After a Single Dose Acellular Pertussis Vaccination

NCT04529720 ·Status: COMPLETED

Pertussis Immunisation and Food Allergy

NCT02490007 ·Status: COMPLETED

Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.

NCT00263679 ·Status: COMPLETED ·Phase: PHASE3

Pertussis Challenge Study in Adults Vaccinated With BPZE1

NCT05461131 ·Status: COMPLETED ·Phase: PHASE2